vs
Riley Exploration Permian, Inc.（REPX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Riley Exploration Permian, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.4倍（$97.3M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -5.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -1.2%）
Riley Exploration Permian, Inc.是一家独立能源企业，专注于美国得克萨斯州与新墨西哥州境内的二叠纪盆地，开展原油、天然气及天然气凝析液的勘探、开发与生产业务，主打低成本陆上储备开发，为北美市场供应稳定能源产品。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
REPX vs RIGL — 直观对比
营收规模更大
REPX
是对方的1.4倍
$69.8M
营收增速更快
RIGL
高出26.5%
-5.3%
两年增速更快
RIGL
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $97.3M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 26.9% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -5.3% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $4.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收REPXRIGL
| Q4 25 | $97.3M | $69.8M | ||
| Q3 25 | $106.9M | $69.5M | ||
| Q2 25 | $85.4M | $101.7M | ||
| Q1 25 | $102.5M | $53.3M | ||
| Q4 24 | $102.7M | $57.6M | ||
| Q3 24 | $102.3M | $55.3M | ||
| Q2 24 | $105.4M | $36.8M | ||
| Q1 24 | $99.7M | $29.5M |
净利润REPXRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $16.3M | $27.9M | ||
| Q2 25 | $30.5M | $59.6M | ||
| Q1 25 | $28.6M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $25.7M | $12.4M | ||
| Q2 24 | $33.5M | $-1.0M | ||
| Q1 24 | $18.8M | $-8.2M |
毛利率REPXRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率REPXRIGL
| Q4 25 | 26.9% | 33.2% | ||
| Q3 25 | 27.0% | 40.9% | ||
| Q2 25 | 33.7% | 60.1% | ||
| Q1 25 | 48.3% | 23.9% | ||
| Q4 24 | 31.2% | 28.9% | ||
| Q3 24 | 17.1% | 25.4% | ||
| Q2 24 | 50.9% | 1.2% | ||
| Q1 24 | 50.7% | -23.6% |
净利率REPXRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 15.3% | 40.2% | ||
| Q2 25 | 35.7% | 58.6% | ||
| Q1 25 | 27.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 25.1% | 22.5% | ||
| Q2 24 | 31.8% | -2.8% | ||
| Q1 24 | 18.8% | -27.9% |
每股收益（稀释后）REPXRIGL
| Q4 25 | $4.02 | $14.11 | ||
| Q3 25 | $0.77 | $1.46 | ||
| Q2 25 | $1.44 | $3.28 | ||
| Q1 25 | $1.36 | $0.63 | ||
| Q4 24 | $0.52 | $0.82 | ||
| Q3 24 | $1.21 | $0.70 | ||
| Q2 24 | $1.59 | $-0.06 | ||
| Q1 24 | $0.94 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $247.9M | $52.5M |
| 股东权益账面价值 | $634.2M | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.39× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资REPXRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务REPXRIGL
| Q4 25 | $247.9M | $52.5M | ||
| Q3 25 | $367.0M | $60.0M | ||
| Q2 25 | $275.2M | $60.0M | ||
| Q1 25 | $249.3M | $60.0M | ||
| Q4 24 | $269.5M | $60.0M | ||
| Q3 24 | $288.6M | $60.0M | ||
| Q2 24 | $322.7M | $60.0M | ||
| Q1 24 | $341.8M | $60.0M |
股东权益REPXRIGL
| Q4 25 | $634.2M | $391.5M | ||
| Q3 25 | $566.5M | $117.6M | ||
| Q2 25 | $556.9M | $81.9M | ||
| Q1 25 | $532.4M | $18.6M | ||
| Q4 24 | $510.6M | $3.3M | ||
| Q3 24 | $507.4M | $-14.6M | ||
| Q2 24 | $489.0M | $-29.9M | ||
| Q1 24 | $434.6M | $-31.7M |
总资产REPXRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.2B | $242.5M | ||
| Q2 25 | $1.0B | $206.7M | ||
| Q1 25 | $994.9M | $176.0M | ||
| Q4 24 | $993.5M | $164.0M | ||
| Q3 24 | $997.9M | $139.4M | ||
| Q2 24 | $1.0B | $128.4M | ||
| Q1 24 | $956.4M | $126.5M |
负债/权益比REPXRIGL
| Q4 25 | 0.39× | 0.13× | ||
| Q3 25 | 0.65× | 0.51× | ||
| Q2 25 | 0.49× | 0.73× | ||
| Q1 25 | 0.47× | 3.23× | ||
| Q4 24 | 0.53× | 18.25× | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.66× | — | ||
| Q1 24 | 0.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $64.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流REPXRIGL
| Q4 25 | $64.9M | $22.0M | ||
| Q3 25 | $63.6M | $24.0M | ||
| Q2 25 | $33.6M | $30.5M | ||
| Q1 25 | $50.4M | $-893.0K | ||
| Q4 24 | $66.4M | $14.5M | ||
| Q3 24 | $72.1M | $21.7M | ||
| Q2 24 | $51.6M | $302.0K | ||
| Q1 24 | $56.1M | $-5.0M |
现金转化率REPXRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 3.90× | 0.86× | ||
| Q2 25 | 1.10× | 0.51× | ||
| Q1 25 | 1.76× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.81× | 1.75× | ||
| Q2 24 | 1.54× | — | ||
| Q1 24 | 2.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
